Q32 Bio Inc. (QTTB)
Nasdaq · Pharmaceutical Preparations · Inc. DE
What they're doing
Between 2026-06-21 and 2026-09-19, public records show 1 signal for Q32 Bio Inc.. Most notable: 2026-07-15: Filed 8-K disclosing material agreement. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.
Generated 2026-09-19 from public records.
Signals, last 12 months
- Material 8-K filingFiled 8-K disclosing material agreement
- Insider buying cluster3 insiders bought $60.0M within 14 days
- Insider purchaseXu Diyong (director) bought $10.0M of stock
- Insider purchaseOrbiMed Capital GP VII LLC (director) bought $10.0M of stock
- Insider purchaseXu Diyong (director) bought $5.0M of stock
- Insider purchaseOrbiMed Capital GP VII LLC (director) bought $5.0M of stock
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing director or officer change
- Material 8-K filingFiled 8-K disclosing material agreement, acquisition or disposition of assets
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-08-25 | Morrison Jodie Pope | director | S | 9,845 | 16.56 | $163,033 |
| 2026-08-25 | Kalowski Lee | officer | S | 3,972 | 16.56 | $65,776 |
| 2026-08-25 | Violette Shelia M. | officer | S | 2,798 | 16.56 | $46,335 |
| 2026-07-16 | Violette Shelia M. | officer | A | 37,500 | 0 | $0 |
| 2026-07-16 | Morrison Jodie Pope | director | A | 132,000 | 0 | $0 |
| 2026-07-16 | Kalowski Lee | officer | A | 53,250 | 0 | $0 |
| 2026-06-30 | Manke Isaac | director | M | 53,521 | 2.8 | $149,859 |
| 2026-05-28 | Xu Diyong | director | P | 1,250,000 | 8 | $10,000,000 |
| 2026-05-28 | Xu Diyong | director | P | 625,000 | 8 | $5,000,000 |
| 2026-05-28 | OrbiMed Capital GP VII LLC | director | P | 625,000 | 8 | $5,000,000 |
| 2026-05-28 | OrbiMed Capital GP VII LLC | director | P | 1,250,000 | 8 | $10,000,000 |
| 2026-05-28 | Xu Diyong | director | P | 1,250,000 | 8 | $10,000,000 |
| 2026-05-28 | Xu Diyong | director | P | 625,000 | 8 | $5,000,000 |
| 2026-05-28 | ORBIMED ADVISORS LLC; OrbiMed Capital GP VII LLC; OrbiMed Genesis GP LLC | director | P | 1,250,000 | 8 | $10,000,000 |
| 2026-05-28 | ORBIMED ADVISORS LLC; OrbiMed Capital GP VII LLC; OrbiMed Genesis GP LLC | director | P | 625,000 | 8 | $5,000,000 |
| 2026-02-25 | Kalowski Lee | officer | S | 3,995 | 4.51 | $18,017 |
| 2026-02-25 | Morrison Jodie Pope | director | S | 9,896 | 4.51 | $44,631 |
| 2026-02-25 | Violette Shelia M. | officer | S | 2,815 | 4.51 | $12,696 |
| 2026-02-25 | Kalowski Lee | officer | S | 3,995 | 4.51 | $18,035 |
| 2026-02-25 | Morrison Jodie Pope | director | S | 9,896 | 4.51 | $44,675 |
| 2026-02-25 | Violette Shelia M. | officer | S | 2,815 | 4.51 | $12,708 |
| 2026-02-24 | Violette Shelia M. | officer | A | 37,500 | 0 | $0 |
| 2026-02-24 | Morrison Jodie Pope | director | A | 132,000 | 0 | $0 |
| 2026-02-24 | Kalowski Lee | officer | A | 53,250 | 0 | $0 |
| 2026-02-24 | Violette Shelia M. | officer | A | 37,500 | 0 | $0 |
| 2026-02-24 | Morrison Jodie Pope | director | A | 132,000 | 0 | $0 |
| 2026-02-24 | Kalowski Lee | officer | A | 53,250 | 0 | $0 |
| 2025-12-02 | Morrison Jodie Pope | director | S | 22,506 | 3.46 | $77,871 |
| 2025-12-02 | Kalowski Lee | officer | S | 9,072 | 3.46 | $31,389 |
| 2025-12-02 | Morrison Jodie Pope | director | S | 22,506 | 3.46 | $77,871 |
| 2025-12-02 | Kalowski Lee | officer | S | 9,072 | 3.46 | $31,395 |
| 2025-08-26 | Morrison Jodie Pope | director | S | 10,494 | 1.8 | $18,889 |
| 2025-08-26 | Violette Shelia M. | officer | S | 2,990 | 1.8 | $5,382 |
| 2025-08-26 | Kalowski Lee | officer | S | 4,240 | 1.8 | $7,632 |
| 2025-08-26 | Morrison Jodie Pope | director | S | 10,494 | 1.8 | $18,900 |
| 2025-08-26 | Violette Shelia M. | officer | S | 2,990 | 1.8 | $5,385 |
| 2025-08-26 | Kalowski Lee | officer | S | 4,240 | 1.8 | $7,636 |
| 2025-02-24 | Kalowski Lee | officer | A | 53,250 | 0 | $0 |
| 2025-02-24 | Morrison Jodie Pope | director | A | 132,000 | 0 | $0 |
| 2025-02-24 | Campagna Jason | officer | A | 37,500 | 0 | $0 |
| 2025-02-24 | Violette Shelia M. | officer | A | 37,500 | 0 | $0 |
| 2025-02-24 | Kalowski Lee | officer | A | 53,250 | 0 | $0 |
| 2025-02-24 | Morrison Jodie Pope | director | A | 132,000 | 0 | $0 |
| 2025-02-24 | Campagna Jason | officer | A | 37,500 | 0 | $0 |
| 2025-02-24 | Violette Shelia M. | officer | A | 37,500 | 0 | $0 |
| 2024-10-15 | Violette Shelia M. | officer | M | 6,000 | 7.29 | $43,740 |
| 2024-10-15 | Violette Shelia M. | officer | M | 6,000 | 7.29 | $43,740 |
| 2024-10-11 | Violette Shelia M. | officer | M | 4,574 | 3.12 | $14,271 |
| 2024-10-11 | Violette Shelia M. | officer | M | 4,574 | 3.12 | $14,271 |
| 2024-10-08 | Violette Shelia M. | officer | M | 13,300 | 3.12 | $41,496 |
Federal contracts
No federal contract actions on record for this recipient mapping.
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
No Wikipedia pageview data linked to this company.
Recent filings
- 2026-09-14 8-K
- 2026-08-27 4
- 2026-08-27 4
- 2026-08-27 4
- 2026-08-14 SCHEDULE 13G/A
- 2026-08-14 SCHEDULE 13G/A
- 2026-08-05 10-Q
- 2026-08-05 8-K
- 2026-07-31 SCHEDULE 13G/A
- 2026-07-28 EFFECT
- 2026-07-28 424B3
- 2026-07-21 4/A
- 2026-07-21 4/A
- 2026-07-21 4/A
- 2026-07-21 4/A
- 2026-07-21 4/A
- 2026-07-21 4/A
- 2026-07-21 4/A
- 2026-07-21 4/A
- 2026-07-20 SCHEDULE 13D/A